Antibiogo: a revolutionary application developed by Doctors Without Borders

Doctors Without Borders will soon deploy its innovative Antibiogo application in several of its laboratories in Mali, Jordan, Yemen and the Central African Republic. This free, open source and offline downloadable Android application will contribute to an increase of information technology to support antimicrobial prescribing in low-and middle-income countries (LMIC).

Continue ReadingAntibiogo: a revolutionary application developed by Doctors Without Borders

2021 Global-PPS results in Russia

In May 2022, the Russian network of hospitals within the Global-PPS project published a new paper in the Tropical Medicine and Infectious Disease journal. The goal of the study was to evaluate prescribing patterns of antimicrobials in COVID-19 patients in several Russian multi-field hospitals, and to quantify the prescribing in relation to quality indicators.

Continue Reading2021 Global-PPS results in Russia

Global-PPS at ECCMID 2022

At the 32st edition of the European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), the Global-PPS team from the University of Antwerp and participants from Georgia, Montenegro, and the Philippines present their latest Global-PPS results. This year, ECCMID will take place for the first time as a hybrid event both online and on-site in Lisbon, Portugal on 23 – 26 April 2022.

Continue ReadingGlobal-PPS at ECCMID 2022

Evaluating the Global Point Prevalence Survey of antimicrobial consumption and resistance in 47 Canadian hospitals

On December 21, 2021, a network of Canadian hospitals published a paper in CMAJ Open, reporting on their Global-PPS results. This study describes antimicrobial use (AMU) based on detailed patient-level data in Canadian hospitals in 2018 in terms of antimicrobial prevalence, indications and agent selection in adult and paediatric medical, surgical and intensive care wards.

Continue ReadingEvaluating the Global Point Prevalence Survey of antimicrobial consumption and resistance in 47 Canadian hospitals

Testimonial: Iranian Global-PPS of Antimicrobial Consumption and Resistance

The Global-PPS in Iran primarily started in 2015 in the Kurdistan University of Medical Sciences, concurrently with the first global attempt for data collection about antibiotic consumption conducted by the University of Antwerp, Belgium. From 2017, the Global-PPS was repeated every year with additionaldata collected in 4 new hospitals in Sanandaj.

Continue ReadingTestimonial: Iranian Global-PPS of Antimicrobial Consumption and Resistance

Implementation of a multidisciplinary antimicrobial stewardship programme in a Philippine tertiary care hospital

Optimizing antimicrobial prescribing in hospitals through antimicrobial stewardship (AMS) is essential in addressing the threat of antimicrobial resistance. This study reports the results of five consecutive PPS in a private tertiary hospital in the Philippines, using the Global-PPS protocol.

Continue ReadingImplementation of a multidisciplinary antimicrobial stewardship programme in a Philippine tertiary care hospital

High use of Watch antibiotics in hospitals in lower- and upper-middle-income countries

On 5 April 2021, the Global-PPS team published a paper in the Journal of Antimicrobial Chemotherapy that focuses on hospital antibiotic prescribing patterns in adult patients according to the WHO Access, Watch and Reserve classification (AWaRe).

Continue ReadingHigh use of Watch antibiotics in hospitals in lower- and upper-middle-income countries

Global-PPS in Iran

The Global-PPS in Iran primarily started in 2015 in two large Iranian University cities, namely Shiraz and Kurdistan Universities of Medical Sciences, concurrently with the first global attempt for data collection about antibiotic consumption conducted by the University of Antwerp, Belgium.

Continue ReadingGlobal-PPS in Iran